Glenmark Pharma

{
  "main_header": {
    "sid": 780863,
    "name": "Glenmark Pharma",
    "stock_name": "Glenmark Pharma",
    "full_name": "Glenmark Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/glenmark-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,233.90",
    "chg": 43.6,
    "chgp": "1.99%",
    "dir": 1,
    "prev_price": "2,190.30",
    "mcapval": "63,140.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532296,
    "symbol": "GLENMARK",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE935A01035",
    "curr_date": "Jul 31, 03:58 PM",
    "curr_time": "16:59 PM",
    "last_traded_at": "Jul 31, 03:58 PM IST",
    "bse_nse_vol": "3.94 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 31, 2026",
    "traded_date_str": "2026 07 31",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/glenmark-pharma-780863-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "SM",
      "url": "https://www.marketsmojo.com/mojopro/stock-of-the-month",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/glenmark-pharma-780863-1&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Glenmark Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-signals-4129531",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlenmarkPharmac_technicaldot_4129531.png",
        "date": "2026-07-31 08:01:49",
        "description": "Glenmark Pharmaceuticals Ltd. has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend as of late July 2026. Despite a recent downgrade in daily price performance, the company’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages. This analysis delves into the evolving technical landscape of Glenmark Pharma, contextualising its price action against broader market movements and sectoral trends."
      },
      {
        "title": "Glenmark Pharmaceuticals Upgraded to Buy on Strong Financials and Technical Rebound",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/glenmark-pharmaceuticals-upgraded-to-buy-on-strong-financials-and-technical-rebound-4128059",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlenmarkPharmac_mojoScore_4128059.png",
        "date": "2026-07-30 08:18:02",
        "description": "Glenmark Pharmaceuticals Ltd. has been upgraded from a Hold to a Buy rating by MarketsMojo as of 29 Jul 2026, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. The mid-cap pharmaceutical company’s robust quarterly performance, attractive valuation metrics, and a shift to a mildly bullish technical trend underpin this positive reassessment."
      },
      {
        "title": "Glenmark Pharmaceuticals Ltd. Shifts to Mildly Bullish Technical Momentum Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-ltd-shifts-to-mildly-bullish-technical-momentum-amid-strong-returns-4127891",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlenmarkPharmac_technicaldot_4127891.png",
        "date": "2026-07-30 08:01:57",
        "description": "Glenmark Pharmaceuticals Ltd. has demonstrated a notable shift in price momentum, transitioning from a mildly bearish to a mildly bullish technical trend. This change is underpinned by a combination of positive signals from key technical indicators including MACD, moving averages, and Bollinger Bands, signalling renewed investor confidence in the mid-cap pharmaceutical player."
      },
      {
        "title": "Glenmark Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4123362",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlenmarkPharmac_technicaldot_4123362.png",
        "date": "2026-07-28 08:03:55",
        "description": "Glenmark Pharmaceuticals Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a marginal day change of 0.05% and a current price of ₹2,194.45, the stock’s technical indicators present a nuanced picture, with some signals pointing to caution while others suggest potential resilience."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-sharp-open-interest-surge-amid-mixed-market-signals-4122824",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlenmarkPharmac_oi_spurts_by_underlying_4122824.png",
        "date": "2026-07-27 15:00:35",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a significant 19.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, reflecting a complex interplay of factors influencing its near-term outlook."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-sharp-open-interest-surge-amid-mixed-market-signals-4122738",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlenmarkPharmac_oi_spurts_by_underlying_4122738.png",
        "date": "2026-07-27 14:00:26",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a notable 15.7% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock’s price performance remains subdued relative to its sector, reflecting a complex interplay of factors influencing trader sentiment and potential directional bets."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-sharp-open-interest-surge-amid-mixed-market-signals-4122671",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlenmarkPharmac_oi_spurts_by_underlying_4122671.png",
        "date": "2026-07-27 13:00:16",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a notable 14.18% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock’s performance remains subdued relative to its sector, reflecting a complex interplay of technical and fundamental factors influencing trader sentiment."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Notable Surge in Derivatives Open Interest Amid Mixed Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-notable-surge-in-derivatives-open-interest-amid-mixed-price-action-4122626",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GlenmarkPharmac_oi_spurts_by_underlying_4122626.png",
        "date": "2026-07-27 12:00:12",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a notable 11.13% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 0.39% gain in the stock price, the pharmaceutical mid-cap’s recent trading patterns reveal a complex interplay of volume dynamics, liquidity, and technical indicators that merit close scrutiny."
      },
      {
        "title": "Glenmark Pharmaceuticals Declines 1.91%: 3 Key Factors Shaping This Week’s Movement",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-declines-191-3-key-factors-shaping-this-weeks-movement-4120673",
        "imagepath": "",
        "date": "2026-07-25 16:05:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Jul:</strong> Stock opens at ₹2,238.95 with marginal gains</p>\n                    <p><strong>22 Jul:</strong> Sharp decline of 1.95% amid broader market weakness</p>\n                    <p><strong>24 Jul:</strong> Significant open interest surge and rating downgrade to Hold</p>\n                    <p><strong>24 Jul:</strong> Technical momentum shifts to sideways trend</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹2,235.90</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹2,193.25</..."
      }
    ],
    "total": 591,
    "sid": "780863",
    "stock_news_url": "https://www.marketsmojo.com/news/glenmark-pharmaceuticals-780863"
  },
  "announcements": [
    {
      "details": "Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 26, 2019, titled \"Glenmark Pharmaceuticals receives ANDA approval for Metformin Hydrochloride Extended-Release Tablets USP,",
      "source": "NSE",
      "caption": "Glenmark Pharmaceuticals Limited - Press Release",
      "datetime": "26-Nov-2019"
    },
    {
      "details": "Glenmark Pharmaceuticals Limited has informed the Exchange regarding Grant of 20000 Options.",
      "source": "NSE",
      "caption": "Glenmark Pharmaceuticals Limited - ESOP/ESOS/ESPS",
      "datetime": "15-Nov-2019"
    },
    {
      "details": "Glenmark Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015",
      "source": "NSE",
      "caption": "Glenmark Pharmaceuticals Limited - Trading Window",
      "datetime": "06-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(31 Jul 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Glenmark Pharmaceuticals Ltd. has declared <strong>250%</strong> dividend, ex-date: 03 Oct 25",
          "dt": "2025-10-03",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Glenmark Pharmaceuticals Ltd. has announced <strong>1:2</strong> stock split, ex-date: 10 Sep 07",
          "dt": "2007-09-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Glenmark Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Signals

2026-07-31 08:01:49

Glenmark Pharmaceuticals Ltd. has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend as of late July 2026. Despite a recent downgrade in daily price performance, the company’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages. This analysis delves into the evolving technical landscape of Glenmark Pharma, contextualising its price action against broader market movements and sectoral trends.

Read full news article

Glenmark Pharmaceuticals Upgraded to Buy on Strong Financials and Technical Rebound

2026-07-30 08:18:02

Glenmark Pharmaceuticals Ltd. has been upgraded from a Hold to a Buy rating by MarketsMojo as of 29 Jul 2026, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. The mid-cap pharmaceutical company’s robust quarterly performance, attractive valuation metrics, and a shift to a mildly bullish technical trend underpin this positive reassessment.

Read full news article

Glenmark Pharmaceuticals Ltd. Shifts to Mildly Bullish Technical Momentum Amid Strong Returns

2026-07-30 08:01:57

Glenmark Pharmaceuticals Ltd. has demonstrated a notable shift in price momentum, transitioning from a mildly bearish to a mildly bullish technical trend. This change is underpinned by a combination of positive signals from key technical indicators including MACD, moving averages, and Bollinger Bands, signalling renewed investor confidence in the mid-cap pharmaceutical player.

Read full news article

Glenmark Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-07-28 08:03:55

Glenmark Pharmaceuticals Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a marginal day change of 0.05% and a current price of ₹2,194.45, the stock’s technical indicators present a nuanced picture, with some signals pointing to caution while others suggest potential resilience.

Read full news article

Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-07-27 15:00:35

Glenmark Pharmaceuticals Ltd. has witnessed a significant 19.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, reflecting a complex interplay of factors influencing its near-term outlook.

Read full news article

Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-07-27 14:00:26

Glenmark Pharmaceuticals Ltd. has witnessed a notable 15.7% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock’s price performance remains subdued relative to its sector, reflecting a complex interplay of factors influencing trader sentiment and potential directional bets.

Read full news article

Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-07-27 13:00:16

Glenmark Pharmaceuticals Ltd. has witnessed a notable 14.18% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock’s performance remains subdued relative to its sector, reflecting a complex interplay of technical and fundamental factors influencing trader sentiment.

Read full news article

Glenmark Pharmaceuticals Sees Notable Surge in Derivatives Open Interest Amid Mixed Price Action

2026-07-27 12:00:12

Glenmark Pharmaceuticals Ltd. has witnessed a notable 11.13% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 0.39% gain in the stock price, the pharmaceutical mid-cap’s recent trading patterns reveal a complex interplay of volume dynamics, liquidity, and technical indicators that merit close scrutiny.

Read full news article

Glenmark Pharmaceuticals Declines 1.91%: 3 Key Factors Shaping This Week’s Movement

2026-07-25 16:05:25

Key Events This Week

20 Jul: Stock opens at ₹2,238.95 with marginal gains

22 Jul: Sharp decline of 1.95% amid broader market weakness

24 Jul: Significant open interest surge and rating downgrade to Hold

24 Jul: Technical momentum shifts to sideways trend

Week Open

₹2,235.90

Week Close

₹2,193.25Read full news article

View All News